scispace - formally typeset
D

Daryl T. Baldwin

Researcher at Genentech

Publications -  20
Citations -  5324

Daryl T. Baldwin is an academic researcher from Genentech. The author has contributed to research in topics: Receptor & Vascular endothelial growth inhibitor. The author has an hindex of 12, co-authored 20 publications receiving 5132 citations.

Papers
More filters
Journal ArticleDOI

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

TL;DR: A cell surface mechanism exists for the regulation of cellular responsiveness to pro-apoptotic stimuli in tumor cells.
Journal ArticleDOI

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

TL;DR: Certain tumours may escape FasL-dependent immune-cytotoxic attack by expressing a decoy receptor that blocks FasL, which was amplified in about half of 35 primary lung and colon tumours studied and DcR3 messenger RNA was expressed in malignant tissue.
Journal ArticleDOI

A novel receptor for Apo2L/TRAIL contains a truncated death domain

TL;DR: Results suggest that DcR2 functions as an inhibitory Apo2L receptor, which contains a cytoplasmic region with a truncated death domain and was particularly abundant in fetal liver and adult testis.
Journal ArticleDOI

IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1

TL;DR: In this article, the identification of interleukin (IL)-17E, a member of the IL-17 family of cytokines, was reported, which induces activation of NF-κB and stimulates production of the proinflammatory chemokine IL-8.